{"id":954877,"date":"2026-04-27T09:40:51","date_gmt":"2026-04-27T13:40:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/"},"modified":"2026-04-27T09:40:51","modified_gmt":"2026-04-27T13:40:51","slug":"exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/","title":{"rendered":"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CARLSBAD, Calif., April  27, 2026  (GLOBE NEWSWIRE) &#8212; Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended March 31, 2026, before the market opens on Monday, May 11, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) that morning to review the Company\u2019s results.<\/p>\n<p align=\"left\">\n        <strong>Conference Call &amp; Webcast:<\/strong>\n      <\/p>\n<ul>\n<li>\n          <strong>U.S. dial-in:<\/strong> 877-407-0890<\/li>\n<li>\n          <strong>International dial-in:<\/strong> +1 201-389-0918<\/li>\n<li>\n          <strong>Webcast:<\/strong> Available via the Exagen Investor Relations website at <a href=\"https:\/\/investors.exagen.com\/\" rel=\"nofollow\" target=\"_blank\">investors.exagen.com<\/a><\/p>\n<\/li>\n<\/ul>\n<p align=\"left\">\n        <strong>Replay:<\/strong> A telephone replay will be available until Monday, May 25, 2026:<\/p>\n<ul>\n<li>\n          <strong>U.S. replay:<\/strong> 877-660-6853<\/li>\n<li>\n          <strong>International replay:<\/strong> +1 201-612-7415<\/li>\n<li>\n          <strong>Replay passcode:<\/strong> 13759736<\/li>\n<li>\n          <strong>Webcast:<\/strong> A recording of the webcast will be available one hour after the call concludes via the Exagen Investor Relations website at <a href=\"https:\/\/investors.exagen.com\/\" rel=\"nofollow\" target=\"_blank\">investors.exagen.com<\/a><\/p>\n<\/li>\n<\/ul>\n<p align=\"left\">\n        <strong>About Exagen Inc.<\/strong>\n      <\/p>\n<p align=\"left\">Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen\u2019s mission is to provide clarity in autoimmune disease decision-making and improve clinical outcomes through its innovative testing portfolio. The company\u2019s flagship product, AVISE\u00ae CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sj\u00f6gren\u2019s disease earlier and with greater accuracy. Exagen\u2019s CLIA-certified, CAP-accredited laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management.<\/p>\n<p align=\"left\">For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pW4vlA-GgT5xkVB5WabAD25yl7xdqA3CKSwEsAFgJamq36UcE_Dxp1K7wPh7UNqQq1nRX1DhAHDAOqqNy9_6-w==\" rel=\"nofollow\" target=\"_blank\">Exagen.com<\/a> or follow Exagen on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uDMU7WVtFy8JuAbcQPHcoe5PLqOTU69LJ6XVjvwM_Y8c3KZ42K0hJfK5wIYescvl4a5J6RteKna3q1GQLVBBlHuKBxQMn9gy97zPXRdtAjJRnnc7hxGiFZYEeKRYk-1LhrwNZ-lQhFbYO02MH9pYLg==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Contact<\/strong>\n      <\/p>\n<p align=\"left\">Tina Jacobsen, CFA<br \/>Exagen Inc.<br \/>ir@exagen.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDMxNDBmZDYtZDMxYy00NzE3LWFmNWEtN2Q4MTM5ZjZiYjNhLTEwMjI1NDUtMjAyNi0wNC0yNy1lbg==\/tiny\/Exagen-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CARLSBAD, Calif., April 27, 2026 (GLOBE NEWSWIRE) &#8212; Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended March 31, 2026, before the market opens on Monday, May 11, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) that morning to review the Company\u2019s results. Conference Call &amp; Webcast: U.S. dial-in: 877-407-0890 International dial-in: +1 201-389-0918 Webcast: Available via the Exagen Investor Relations website at investors.exagen.com Replay: A telephone replay will be available until Monday, May 25, 2026: U.S. replay: 877-660-6853 International replay: +1 201-612-7415 Replay passcode: 13759736 Webcast: A recording of the webcast &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-954877","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CARLSBAD, Calif., April 27, 2026 (GLOBE NEWSWIRE) &#8212; Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended March 31, 2026, before the market opens on Monday, May 11, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) that morning to review the Company\u2019s results. Conference Call &amp; Webcast: U.S. dial-in: 877-407-0890 International dial-in: +1 201-389-0918 Webcast: Available via the Exagen Investor Relations website at investors.exagen.com Replay: A telephone replay will be available until Monday, May 25, 2026: U.S. replay: 877-660-6853 International replay: +1 201-612-7415 Replay passcode: 13759736 Webcast: A recording of the webcast &hellip; Continue reading &quot;Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-27T13:40:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026\",\"datePublished\":\"2026-04-27T13:40:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/\"},\"wordCount\":301,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/\",\"name\":\"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI=\",\"datePublished\":\"2026-04-27T13:40:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/","og_locale":"en_US","og_type":"article","og_title":"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026 - Market Newsdesk","og_description":"CARLSBAD, Calif., April 27, 2026 (GLOBE NEWSWIRE) &#8212; Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended March 31, 2026, before the market opens on Monday, May 11, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) that morning to review the Company\u2019s results. Conference Call &amp; Webcast: U.S. dial-in: 877-407-0890 International dial-in: +1 201-389-0918 Webcast: Available via the Exagen Investor Relations website at investors.exagen.com Replay: A telephone replay will be available until Monday, May 25, 2026: U.S. replay: 877-660-6853 International replay: +1 201-612-7415 Replay passcode: 13759736 Webcast: A recording of the webcast &hellip; Continue reading \"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-27T13:40:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026","datePublished":"2026-04-27T13:40:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/"},"wordCount":301,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/","name":"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI=","datePublished":"2026-04-27T13:40:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY5NDI0OCM3NTQ4MDg0IzIwMTA5NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954877","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=954877"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/954877\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=954877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=954877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=954877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}